Revolution Medicines (RVMD)
(Delayed Data from NSDQ)
$45.42 USD
-0.76 (-1.65%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $45.94 +0.52 (1.14%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Revolution Medicines, Inc. (RVMD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$56.79 | $73.00 | $38.00 | 22.98% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Revolution Medicines, Inc. comes to $56.79. The forecasts range from a low of $38.00 to a high of $73.00. The average price target represents an increase of 22.98% from the last closing price of $46.18.
Analyst Price Targets (14)
Broker Rating
Revolution Medicines, Inc. currently has an average brokerage recommendation (ABR) of 1.07 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 1.07 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, 14 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 93.33% and 6.67% of all recommendations. A month ago, Strong Buy made up 93.33%, while Buy represented 6.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 14 | 14 | 14 | 14 | 12 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.07 | 1.07 | 1.07 | 1.07 | 1.08 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/8/2024 | Wedbush Securities | Robert Driscoll | Strong Buy | Strong Buy |
8/7/2024 | Cowen & Co. | Marc Frahm | Strong Buy | Strong Buy |
8/7/2024 | Piper Sandler | Joseph M Catanzaro | Strong Buy | Strong Buy |
8/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/17/2024 | UBS | Eliana Merle | Strong Buy | Strong Buy |
7/16/2024 | Needham & Company | Ami Fadia | Moderate Buy | Moderate Buy |
7/16/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/16/2024 | Raymond James | Laura Prendergast | Strong Buy | Strong Buy |
7/16/2024 | H.C. Wainwright & Co. | Robert Burns | Strong Buy | Strong Buy |
7/15/2024 | SVB Securities | Jonathan W Chang | Strong Buy | Strong Buy |
7/12/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
7/8/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
1/12/2024 | Guggenheim Securities | Michael Schmidt | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.07 |
ABR (Last week) | 1.07 |
# of Recs in ABR | 15 |
Average Target Price | $56.79 |
LT Growth Rate | 2.10% |
Industry | Medical - Drugs |
Industry Rank by ABR | 84 of 253 |
Current Quarter EPS Est: | -0.89 |
RVMD FAQs
Revolution Medicines, Inc. (RVMD) currently has an average brokerage recommendation (ABR) of 1.07 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms.
The average price target for Revolution Medicines, Inc. (RVMD) is $56.79. The current on short-term price targets is based on 11 reports.
The forecasts for Revolution Medicines, Inc. (RVMD) range from a low of $38 to a high of $73. The average price target represents a increase of $25.03 from the last closing price of $45.42.
The current UPSIDE for Revolution Medicines, Inc. (RVMD) is 25.03%
Based on short-term price targets offered by 14 analysts, the average price target for Revolution Medicines, Inc. comes to $56.79. The forecasts range from a low of $38.00 to a high of $73.00. The average price target represents an increase of 22.98% from the last closing price of $46.18.